Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: May 2020

Sanofi plans to unload a $13B Regeneron stake. Is a rare disease buyout next?

Sanofi plans to unload a $13B Regeneron stake. Is a rare disease buyout next? esagonowsky Tue, 05/26/2020 – […]

May 26, 2020 Uncategorized

Fighting hospital germs with UVC light-emitting diodes

According to the RKI, 400,000 to 600,000 infections with hospital germs occur in Germany every year – about […]

May 26, 2020 Uncategorized

mHealth: inexpensive retinal diagnostics via smartphone

Retinal damage due to diabetes is now considered the most common cause of blindness in working-age adults. In […]

May 26, 2020 Uncategorized

Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review

AbstractObjectiveTo appraise the availability, quality, and inclusivity of clinical guidelines produced in the early stage of the coronavirus […]

May 26, 2020 COVID-19

Children in care can be vaccinated against parents’ wishes without court action

Local authorities will be allowed to get children in care vaccinated despite opposition from their parents without asking […]

May 26, 2020 Paediatrics, Shared decision making, Too much medicine

Covid-19 and acute kidney injury in hospital: summary of NICE guidelines

What you need to knowAcute kidney injury (AKI) may be common in patients with covid-19 and is associated […]

May 26, 2020 Guideline summaries

Physician Moms Group: the support network that’s needed more than ever during the covid-19 pandemic

Hala Sabry was pregnant with twins—her second and third children in 18 months—and was trying to balance parenting […]

May 26, 2020 Uncategorized

Lyme borreliosis: diagnosis and management

AbstractLyme borreliosis is the most common vectorborne disease in the northern hemisphere. It usually begins with erythema migrans; […]

May 26, 2020 State of the Art

Novavax launches trial of coronavirus vaccine candidate

The firm has begun enrolling patients in the Phase I portion of the trial

May 26, 2020 Uncategorized

New US approval for Takeda’s Alunbrig

The move is based on data showing Alunbrig’s superiority over crizotinib as first-line treatment of metastatic ALK+ NSCLC

May 26, 2020 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 9 10 11 … 52 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy